Medivate Partners LLC

Investor type

VC

Founded

2012

AUM

$80 M

Location

Seoul, Seoul, South Korea

Investment Ticket

$10-50 m

Investment Stage

Series B

Region of investment

Asia
Investor profile last updated: 21 August, 2026

Profile

Founded in 2012, Medivate is one of the first private equity firms in Korea with the expertise in value investing cross-border life sciences industry. Medivate has been raised ~$80 million capital into 5 portfolio companies which include clinical stage biotech companies and contract development manufacturing organizations (CDMOs). Medivate’s management team has proven record in life sciences industry provides competitive advantage by leveraging strategic partnership with the portfolio companies, a key to the successful investment returns.

Industry

Healthcare Services Biotechnology Medical Devices Pharmaceuticals MedTech Life Sciences

Contacts

Name
Title
Email
avatar
Paul H. Kim CEO & Managing Partner
CEO & Managing Partner
-
avatar
Katie Oh Senior Principal
Senior Principal
-
Upgrade to see contacts
avatar
DPYKpy2IL8RZb1Qw DPYKpy2IL8RZb1Qw
DPYKpy2IL8RZb1Qw
avatar
DPYKpy2IL8RZb1Qw DPYKpy2IL8RZb1Qw
DPYKpy2IL8RZb1Qw
avatar
DPYKpy2IL8RZb1Qw DPYKpy2IL8RZb1Qw
DPYKpy2IL8RZb1Qw
Investment-team contacts for Medivate Partners LLC — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Medivate Partners LLC

Medivate Partners LLC is a venture capital firm. It backs companies at Series B, writing tickets of $10-50 m.
Medivate Partners LLC is located in Seoul, Seoul, South Korea.
Medivate Partners LLC was founded in 2012.
Medivate Partners LLC invests in companies and startups in Healthcare Services, Biotechnology, Medical Devices, Pharmaceuticals, MedTech, Life Sciences.
Medivate Partners LLC invests in companies and startups in Asia.
Medivate Partners LLC invests in companies and startups at Series B.
Medivate Partners LLC usually invests $10-50 m on average.
Medivate Partners LLC has around $80m assets under management.
Medivate Partners LLC can be reached through its website medivatepartners.com/en/html/main.html and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Medivate Partners LLC — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Medivate Partners LLC directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 21 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.